FOLH1 and neoplasm: Inverse analogues [68Ga]Ga-P15 and [68Ga]Ga-P16 exhibited lower plasma protein binding compared to [68Ga]Ga-PSMA-617, however PET/CT imaging and biodistribution studies confirmed specific tumour targeting for all inhibitors.